Search the Newsreel

IAMGOLD Corporation 2026 Q2 - Results - Earnings Call Presentation (TSX:IMG:CA) 2026-08-07

Amgen Inc. $AMGN Shares Acquired by Czech National Bank

The Czech National Bank increased its stake in Amgen Inc. by 4.8% in the second quarter, acquiring an additional 6,969 shares and bringing its total holdings to 153,622 shares valued at $55.6 million. This comes as Amgen reported strong second-quarter results, exceeding analyst expectations …

PensionDanmark Pensionsforsikringsaktieselskab Grows Stake in Amgen Inc. $AMGN

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Amgen Inc. by 12.3% in the second quarter, bringing its total ownership to 108,300 shares valued at approximately $39.2 million. This comes as Amgen reported strong quarterly results, with a 9.5% revenue increase and raised 2026 adjusted EPS …

MDA SPACE APPOINTS JOHN FARRELL & STEPHEN SPENGLER TO ITS BOARD OF DIRECTORS

Appointments bring additional manufacturing, telecommunications and satellite expertise to support company's next phase of growth. TORONTO, Aug. 7, 2026 /CNW/ -- MDA Space Ltd. (TSX: MDA) (NYSE: MDA), a trusted mission partner to the rapidly expanding global space industry, is pleased to announce the …

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

Pfizer, Merck, and Amgen are expanding their cancer portfolios, leading to increased speculation about smaller oncology companies like Sellas Life Sciences (SLS) and ImmunityBio (IBRX) being potential acquisition targets. Pfizer's Seagen portfolio and Padcev, Merck's sac-TMT, and Amgen's T-cell engagers and Imdelltra are key …

IAMGOLD Corp. (IAG) Misses Q2 EPS by 12c

IAMGOLD Corp. (IAG) reported its Q2 earnings, missing analyst expectations for both EPS and revenue. The company posted an EPS of $0.42, which was $0.12 lower than the estimated $0.54, and revenue came in at $856.9 million against a consensus estimate of $932.83 million.

MGIC Investment Corp (MTG) CEO Timothy Mattke Sells 137,113 Shar

MGIC Investment Corp (MTG) CEO Timothy Mattke sold 137,113 shares of the company on August 5, 2026, for approximately $4.18 million. This sale continues a trend of insider selling over the past year, with 20 insider sells and zero buys, signaling a potentially bearish …

IAMGOLD Non-GAAP EPS of $0.42 misses by $0.02, revenue of $856.9M misses by $21.21M

* IAMGOLD press release [https://seekingalpha.com/filing/309923403] (IAG [https://seekingalpha.com/symbol/IAG]): Q2 Non-GAAP EPS of $0.42 misses by $0.02. * Revenue of $856.9M (+47.5% Y/Y) misses by $21.21M. * Attributable gold production was 188,100 ounces in the second quarter and 371,700 ounces year-to-date (“YTD”), with the Company on …

MGE Energy boosts earnings on renewable investment gains

MGE Energy (MGEE) reported increased earnings for Q2 2026, with GAAP earnings rising to $0.89 per share from $0.72 a year prior, largely due to strategic capital investments in renewable energy projects and investment gains. While operating revenues saw a modest rise, operating income …

IAMGOLD appoints Catherine McLeod-Seltzer to board

IAMGOLD Corporation has announced that Catherine McLeod-Seltzer will join its board of directors on September 1, 2026. McLeod-Seltzer brings over 40 years of mining industry experience, including executive roles and board memberships at companies like Teck Resources Limited and Kinross Gold Corporation. Her extensive …

IAMGOLD Reports Second Quarter 2026 Results

All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - IAMGOLD Corporation (NYSE: IAG) (TSX: IMG) ("IAMGOLD" or the "Company") today reported its financial and operating results for the second quarter ended June 30, 2026. …

IAMGOLD Announces Appointment of Catherine McLeod-Seltzer to the Board of Directors

All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - IAMGOLD Corporation (TSX: IMG) (NYSE: IAG) ("IAMGOLD" or the "Company") today announced that Ms. Catherine McLeod-Seltzer has been appointed to the Company's board of directors …

MGIC Investment (NYSE: MTG) CEO sells 137,113 shares in 10b5-1 trade

MGIC Investment Corp CEO Timothy J. Mattke sold 137,113 shares of common stock on August 5, 2026, at a weighted average price of $30.517 per share, totaling approximately $4.18 million. This transaction was executed under a Rule 10b5-1 trading plan adopted on May 4, …

IAMGold earnings up next: Can margins hold amid gold retreat?

IAMGold Corporation is preparing to report its second-quarter earnings, with investors focused on whether the gold miner can maintain strong profit margins despite a significant retreat in gold prices. Analysts anticipate earnings of 50 cents per share on $932.8 million in revenue, a sequential …

MGIC Investment Corp (MTG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MGIC Investment Corp (MTG), highlighting its current earnings forecast score of 6.00 and an average price target of $27.50 from 6 analysts. It details expected future EPS and revenue figures, and compares MTG's analyst ratings to its …

Lazard Asset Management LLC Invests $1.04 Million in Mistras Group Inc $MG

Lazard Asset Management LLC has acquired a new stake of 70,369 shares, valued at $1.04 million, in Mistras Group Inc (NYSE:MG) during the first quarter. This makes Lazard Asset Management LLC the owner of approximately 0.22% of Mistras Group. Other institutional investors have also …

MGE Energy (MGEE) Stock Shrugs Off Profit Margin Strength And Flat Revenue

MGE Energy's stock saw minimal movement despite reporting strong profitability with a net profit margin near 20% and increased net income and EPS. While revenue remained flat year-over-year, the market's subdued reaction suggests investors view these results as business as usual for a regulated …

Wynn Resorts (NASDAQ:WYNN) Price Target Raised to $130.00 at Argus

Argus has raised its price target for Wynn Resorts (NASDAQ:WYNN) to $130.00 from $115.00, maintaining a "buy" rating, indicating a potential upside of approximately 28%. This comes after Wynn Resorts reported strong Q2 2026 earnings, surpassing analyst expectations with $1.24 EPS and revenue of …

Amgen separates from weak drugmaker group, but 31% fair-value gap raises the bar

AMGN added 2.4% in the week to 31 July and sits only 3.2% below its 52-week high, with the Trend Signal active but volume confirmation still modest.

Mirador Capital Partners LP Acquires New Holdings in MGM Resorts International $MGM

Mirador Capital Partners LP has acquired 50,305 shares of MGM Resorts International, valued at approximately $2.4 million, during the second quarter. This move is part of broader institutional investment, with such entities collectively owning 68.11% of MGM's outstanding shares. Despite varying analyst opinions, MGM …

Trilogy Capital Inc. Has $302,000 Stock Holdings in Amgen Inc. $AMGN

Trilogy Capital Inc. significantly reduced its stake in Amgen Inc. by 91.8% in the second quarter, now holding 833 shares valued at approximately $302,000. Despite this, Amgen exceeded second-quarter expectations with adjusted earnings of $6.29 per share and revenue of $10.05 billion, and announced …

Wynn Resorts (WYNN) Stock Jumps As Profit Recovery Gains Credibility

Wynn Resorts (WYNN) stock saw a significant jump after its Q2 report, driven by firming profitability, with net income from ongoing operations reaching roughly US$140m. While the company demonstrates strong property-level profitability in Macau and Las Vegas, concerns persist regarding its elevated net debt …

Amgen (AMGN) Stock Jumps As Raised Guidance Meets Mounting Risks

Amgen's stock jumped by 5% after its Q2 2026 earnings report, with revenue exceeding US$10 billion and basic EPS above US$4, leading to lifted full-year guidance. While new drugs and biosimilars are driving growth, the company faces significant risks including regulatory issues, product concentration, …

Iamgold (IAG) Earnings Date and Reports 2026 $IAG

Red Rock Resorts (RRR) Q2 2026 Earnings Call Transcript

Red Rock Resorts (RRR) reported Q2 2026 net revenues of $510.3 million, down 3.0%, and net income of $76.6 million, a 29.3% decrease, primarily due to the absence of a one-time payment and construction disruptions. Despite these challenges, Las Vegas operations delivered the second-highest …

MGE Energy (NASDAQ:MGEE) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPS

MGE Energy (NASDAQ:MGEE) announced its quarterly earnings, reporting $0.89 EPS, surpassing analyst estimates by $0.12. Despite beating earnings, the company's revenue of $161.19 million fell short of the $166.37 million consensus. The utilities provider also declared a quarterly dividend of $0.475 per share, representing …

Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ...

Amgen Inc. reported strong Q2 2026 earnings with total revenues exceeding $10 billion, a 10% year-over-year increase, driven by double-digit sales growth in 22 products and significant contributions from key growth drivers like Repatha, EVENITY, and TEZSPIRE. The company also raised its 2026 revenue …

Press Release: MGE Energy Reports Second-Quarter 2026 Earnings

MGE Energy (MGEE) reported second-quarter 2026 earnings of $0.68 per share, a decrease from $0.74 per share in the same period last year. The decline was primarily attributed to warmer weather reducing electric and natural gas sales and higher operating and maintenance expenses, partially …

A Look at Amgen Inc (AMGN) After 4.6% Gain -- GF Value $353.96 v

Amgen Inc. (AMGN) shares recently rose 4.6% to $407.83, significantly above its GF Value™ of $353.96, indicating the stock is 15.2% overvalued. Despite a strong GF Score™ of 80/100, driven by high profitability and growth, its low momentum and financial strength rankings, alongside a …

MGM Resorts International stock underperforms Wednesday when compared to competitors

Shares of MGM Resorts International (MGM) fell 2.65% to $44.51 on Wednesday, underperforming the broader market. This drop occurred on a mixed trading day, with the Dow Jones Industrial Average rising and the S&P 500 Index falling. The company's stock closed 13.72% below its …

AMG Critical Materials (ENXTAM:AMG) Stock Looks Near Fair Value After 35% Gain

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. AMG Critical Materials stock has returned 35.0% over the past year, and after that …

Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, TD Cowen Analyst Says

TD Cowen has raised its price target for Amgen (NASDAQ:AMGN) to $452 from $420, maintaining a "Buy" rating and suggesting an 11.3% upside. This comes after Amgen exceeded Q2 earnings expectations with EPS of $6.29 and revenue of $10.05 billion, driven by newer products, …

MGIC INVESTMENT CORP SEC Filing (Aug 5, 2026)

This article details an SEC Form 144 filing by MGIC Investment Corp (MTG) on August 5, 2026. The filing indicates a proposed sale of 137,113 shares of common stock with an aggregate market value of $4,234,049.44, acquired through restricted stock vesting. The document also …

MGIC Investment (MTG) After Q2 Earnings With Capital Returns And Fair Value In Focus

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. MGIC Investment (MTG) attracted fresh attention after its Q2 2026 earnings on July 29, which showed slightly softer revenue but higher adjusted earnings …

Amgen Inc Stock (AMGN) Moved Up by 4.57% on Aug 5: Drivers Behind the Movement

Amgen Inc. (AMGN) saw its stock rise by 4.57% on August 5th, driven by a strong quarterly earnings report that surpassed expectations and increased full-year guidance. Positive clinical trial updates for its obesity drug MariTide also boosted investor confidence, with analysts raising price targets …

Amgen Extends Obesity Trial, Sharpening Its Long-Term Weight-Loss Bet

Amgen Inc. announced an update on its Phase 3 MARITIME-1-EXTENSION study for its obesity drug, maridebart cafraglutide (AMG 133 or MariTide). The trial aims to assess the long-term efficacy and safety of the drug in helping obese or overweight individuals maintain weight loss and …